{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:44:10Z","timestamp":1769067850847,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"DOI":"10.7759\/cureus.101998","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:05:43Z","timestamp":1769011543000},"source":"Crossref","is-referenced-by-count":0,"title":["Causal Effects Between Antibody-Mediated Immune Responses and Parkinson\u2019s Disease: Insights from Genetic Studies"],"prefix":"10.7759","author":[{"given":"Fengyun","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza C","year":"2019","unstructured":"Raza C, Anjum R, Shakeel NU. Parkinson's disease: mechanisms, translational models and management strategies. Life Sci. 2019, 226:77-90. 10.1016\/j.lfs.2019.03.057","journal-title":"Life Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su D","year":"2025","unstructured":"Su D, Cui Y, He C, et al.. Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025, 388:e080952. 10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris HR","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson's disease. Lancet Neurol. 2024, 403:293-304. 10.1016\/s0140-6736(23)01478-2","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202279","article-title":"Infection and risk of Parkinson\u2019s disease","volume":"11","author":"Smeyne RJ","year":"2021","unstructured":"Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and risk of Parkinson\u2019s disease. J Parkinsons Dis. 2021, 11:31-43. 10.3233\/JPD-202279","journal-title":"J Parkinsons Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2019.8.2.67","article-title":"Mendelian randomization analysis in observational epidemiology","volume":"8","author":"Lee K","year":"2019","unstructured":"Lee K, Lim CY. Mendelian randomization analysis in observational epidemiology. J Lipid Atheroscler. 2019, 8:67-77. 10.12997\/jla.2019.8.2.67","journal-title":"J Lipid Atheroscler"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01743-3","article-title":"A causal relationship between type 1 diabetes and risk of systemic sclerosis: a bidirectional two-sample Mendelian randomization study","volume":"17","author":"Huang H","year":"2025","unstructured":"Huang H, Yu B, Yu F, Wu ZZ, Xu D, Zhang LL. A causal relationship between type 1 diabetes and risk of systemic sclerosis: a bidirectional two-sample Mendelian randomization study. Diabetol Metab Syndr. 2025, 17:195. 10.1186\/s13098-025-01743-3","journal-title":"Diabetol Metab Syndr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2016.12.033","article-title":"\"Mendelian randomization\": an approach for exploring causal relations in epidemiology","volume":"145","author":"Gupta V","year":"2017","unstructured":"Gupta V, Walia GK, Sachdeva MP. \"Mendelian randomization\": an approach for exploring causal relations in epidemiology. Public Health. 2017, 145:113-9. 10.1016\/j.puhe.2016.12.033","journal-title":"Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious disease agents: a genome-wide and HLA association study","volume":"7","author":"Butler-Laporte G","year":"2020","unstructured":"Butler-Laporte G, Kreuzer D, Nakanishi T, Harroud A, Forgetta V, Richards JB. Genetic determinants of antibody-mediated immune responses to infectious disease agents: a genome-wide and HLA association study. Open Forum Infect Dis. 2020, 7:ofaa450. 10.1093\/ofid\/ofaa450","journal-title":"Open Forum Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki MI","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al.. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023, 613:508-18. 10.1038\/s41586-022-05473-8","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000081","article-title":"Methodological challenges in mendelian randomization","volume":"25","author":"VanderWeele TJ","year":"2014","unstructured":"VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M, Kraft P. Methodological challenges in mendelian randomization. Epidemiology. 2014, 25:427-35. 10.1097\/EDE.0000000000000081","journal-title":"Epidemiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess S","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011, 40:755-64. 10.1093\/ije\/dyr036","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz749","article-title":"Bayesian weighted Mendelian randomization for causal inference based on summary statistics","volume":"36","author":"Zhao J","year":"2020","unstructured":"Zhao J, Ming J, Hu X, Chen G, Liu J, Yang C. Bayesian weighted Mendelian randomization for causal inference based on summary statistics. Bioinformatics. 2020, 36:1501-8. 10.1093\/bioinformatics\/btz749","journal-title":"Bioinformatics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin CA","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017, 318:1925-6. 10.1001\/jama.2017.17219","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22207","article-title":"Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner's perspective","volume":"43","author":"Ong JS","year":"2019","unstructured":"Ong JS, MacGregor S. Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner's perspective. Genet Epidemiol. 2019, 43:609-16. 10.1002\/gepi.22207","journal-title":"Genet Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(03)00543-7","article-title":"Epstein-Barr virus-recent advances","volume":"3","author":"Macsween KF","year":"2003","unstructured":"Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis. 2003, 3:131-40. 10.1016\/s1473-3099(03)00543-7","journal-title":"Lancet Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00674-15","article-title":"Kinetics of Epstein-Barr virus (EBV) neutralizing and virus-specific antibodies after primary infection with EBV","volume":"23","author":"Bu W","year":"2016","unstructured":"Bu W, Hayes GM, Liu H, et al.. Kinetics of Epstein-Barr virus (EBV) neutralizing and virus-specific antibodies after primary infection with EBV. Clin Vaccine Immunol. 2016, 23:363-9. 10.1128\/CVI.00674-15","journal-title":"Clin Vaccine Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.4.358","article-title":"Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis","volume":"87","author":"Hsieh JC","year":"2002","unstructured":"Hsieh JC, Lue KH, Lee YL. Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis. Arch Dis Child. 2002, 87:358. 10.1136\/adc.87.4.358","journal-title":"Arch Dis Child"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.816098","article-title":"Epstein-Barr virus and neurological diseases","volume":"8","author":"Zhang N","year":"2021","unstructured":"Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr virus and neurological diseases. Front Mol Biosci. 2021, 8:816098. 10.3389\/fmolb.2021.816098","journal-title":"Front Mol Biosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg3032","article-title":"Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis","volume":"9","author":"Thomas OG","year":"2023","unstructured":"Thomas OG, Bronge M, Tengvall K, et al.. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis. Sci Adv. 2023, 9:eadg3032. 10.1126\/sciadv.adg3032","journal-title":"Sci Adv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.09.009","article-title":"BK and JC virus: a review","volume":"68","author":"Pinto M","year":"2014","unstructured":"Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014, 68:S2-8. 10.1016\/j.jinf.2013.09.009","journal-title":"J Infect"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp332","article-title":"Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma","volume":"101","author":"Carter JJ","year":"2009","unstructured":"Carter JJ, Paulson KG, Wipf GC, et al.. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst. 2009, 101:1510-22. 10.1093\/jnci\/djp332","journal-title":"J Natl Cancer Inst"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457061-causal-effects-between-antibody-mediated-immune-responses-and-parkinsons-disease-insights-from-genetic-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:05:44Z","timestamp":1769011544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457061-causal-effects-between-antibody-mediated-immune-responses-and-parkinsons-disease-insights-from-genetic-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.101998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}